What we do Starsource Multitrade Ltd, formerly Chemo Pharma Laboratories Ltd, transitioned from pharmaceuticals to acquiring businesses in power and chemicals, aiming growth via diversification. |
Founded in 1,942 |
Market share Small player with diversified interests, entering new sectors with growth potential. |
Problem solved Seeks to revive and grow sick companies by leveraging cash resources and entering promising sectors like power and chemicals. |
Top clients or who we serve Business segment clients in power and chemicals; focuses on B2B sectors. |
Key management Ruchit Mehta (MD & CEO), Utsav Trivedi (CFO) appointed 2025; leadership steering new growth directions. |
Our journey and innovations Established in 1942 in pharmaceuticals; exited pharma due to competition; repositioned for acquisitions in power and chemicals. |
Where we operate Primarily India, with future plans possibly extending to related sectors and markets. |
Top products or what we offer Currently proposing acquisitions in power and chemicals; no active pharma products. |
Top brands - |
Raw materials needed - |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue currently from other income; no operational sales recorded recently; likely cyclical as new business unfolds. |
Our industry position Emerging player shifting focus; no significant market share yet in new segments. |
Financial highlights FY2025 revenue nil; other income Rs. 6.2 million; net profit Rs. 3.4 million; conserving funds, no dividend declared. |
Geographical revenue split - |
Order book - |
Whats driving growth Strategic diversification into power and chemical sectors; acquiring companies with strong potential. |
Our future plans Advance negotiations to acquire businesses in power and chemicals; focus on rehabilitation and growth. |
Our green promise - |
Our people and values Committed workforce with focus on transparency, risk management, and stakeholder value. |
Key challenges ahead Risks in acquiring and turning around sick companies; regulatory and market competition challenges. |
Interesting facts Company has pivoted from pharmaceuticals to power and chemicals after nearly 80 years, leveraging available cash resources. |
Risks and strategy Adopts formal risk management policy; strategy focused on cautious acquisition and rehabilitation of targeted businesses. |
